We are live on
!
Find out more
State Street SPDR S&P Pharmaceuticals ETF
XPH
XPH
78 hedge funds and large institutions have $107M invested in State Street SPDR S&P Pharmaceuticals ETF in 2021 Q4 according to their latest regulatory filings, with 17 funds opening new positions, 23 increasing their positions, 17 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
35% more repeat investments, than reductions
Existing positions increased: 23 | Existing positions reduced: 17
31% more first-time investments, than exits
New positions opened: 17 | Existing positions closed: 13
6% more capital invested
Capital invested by funds: $101M → $107M (+$5.64M)
3.9% more ownership
Funds ownership: 43.47% → 47.37% (+3.9%)
0% more funds holding
Funds holding: 78 → 78 (0)
48% less call options, than puts
Call options by funds: $452K | Put options by funds: $872K
Holders
78
Holders Change
–
Holders Change %
0%
% of All Funds
1.2%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
17
Increased
23
Reduced
17
Closed
13
Calls
$452K
Puts
$872K
Net Calls
-$420K
Net Calls Change
-$420K
Top Buyers
| 1 |
Morgan Stanley
New York
|
+$6.36M |
| 2 |
CF
Centaurus Financial
Anaheim,
California
|
+$2.7M |
| 3 |
MCM
MAI Capital Management
Independence,
Ohio
|
+$2.49M |
| 4 |
FIM
FWL Investment Management
Dallas,
Texas
|
+$1.72M |
| 5 |
TAM
Tocqueville Asset Management
New York
|
+$1.63M |
Top Sellers
| 1 |
BNP Paribas Financial Markets
Paris,
France
|
-$4.74M |
| 2 |
Goldman Sachs
New York
|
-$2.33M |
| 3 |
Bank of America
Charlotte,
North Carolina
|
-$1.64M |
| 4 |
IMC Chicago
Chicago,
Illinois
|
-$527K |
| 5 |
FTUS
Flow Traders U.S.
New York
|
-$378K |
